Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |